Global Health Ventures to Initiate Prototype Manufacturing of a Sublingual Anti-Anxiety Drug

VANCOUVER, BRITISH COLUMBIA–(Marketwire - July 29, 2010) - Global Health Ventures Inc. (OTCBB:GHLV) (the “Company”), a specialty pharmaceutical company today announced that it has signed an agreement with Carter Pharmaceutical of Toronto, Canada, to manufacture the prototype of its anti-anxiety drug “Relax-B”. Together, the companies will manufacture about 10,000 pills for carrying out the …